Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × NIH × Canvaxin × Clear all

Phase

Status

Sponsor Class

INDUSTRY 2 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Radiotherapy 100 Cyclophosphamide 91 Cisplatin 71 Carboplatin 62 Etoposide 58 Fluorouracil 56 Vincristine 54 Doxorubicin 54 Chemotherapy, Adjuvant 51 Peripheral Blood Stem Cell Transplantation 45 Paclitaxel 45 Filgrastim 45 Gemcitabine 41 Cytarabine 40 Neoadjuvant Therapy 36 Leucovorin 33 Docetaxel 32 Melphalan 30 Methotrexate 27 Oxaliplatin 26 Immunohistochemistry 23 Gene Expression Profiling 23 Ifosfamide 22 Amplified Fragment Length Polymorphism Analysis 21 Prednisolone 19 Irinotecan 19 Dexamethasone 19 aldesleukin 18 Prednisone 18 Interferon-alpha 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00128583 2013-12-19

Vaccine Therapy in Treating Patients With Malignant Melanoma

National Cancer Institute (NCI)

Phase 2 Unknown

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡